Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bayer
University of California, Irvine
ViroMissile, Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
MacroGenics
Alliance for Clinical Trials in Oncology
University of Nebraska
Adela, Inc
Perspective Therapeutics
Var2 Pharmaceuticals
Stanford University
Mayo Clinic
Tanabe Pharma America, Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Travera Inc
GONGCHU Biotechnology Co., Ltd
Lantheus Medical Imaging
Jonsson Comprehensive Cancer Center
University of Pittsburgh
University of California, Irvine
Cancer Research UK
Chinese University of Hong Kong
Stanford University
Taiho Pharmaceutical Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Second Affiliated Hospital of Guangzhou Medical University
BioEclipse Therapeutics